These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 21543106)
1. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder. Liu DC; Yang ZL Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106 [TBL] [Abstract][Full Text] [Related]
2. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder. Xiong L; Yang Z; Yang L; Liu J; Miao X J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153 [TBL] [Abstract][Full Text] [Related]
3. [Expression of ephrin-A7 and metadherin and its clinicopathological significances in the benign and malignant lesions of gallbladder]. Liu DC; Yang ZL Zhonghua Wai Ke Za Zhi; 2011 Mar; 49(3):250-5. PubMed ID: 21609571 [TBL] [Abstract][Full Text] [Related]
4. Expression of CDC6 and GDF-9 and their clinicopathological significances in benign and malignant lesions of the gallbladder. Shu GS; Yang LP; Yang ZL; Jiang S Cancer Biomark; 2012; 11(2-3):107-14. PubMed ID: 23011157 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 expression in benign and malignant lesions of the gallbladder. Yuan Y; Yang ZL; Zou Q; Cao LF; Tan XG; Jiang S; Miao XY Pol J Pathol; 2013 Apr; 64(1):44-51. PubMed ID: 23625600 [TBL] [Abstract][Full Text] [Related]
6. Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma. Liu DC; Yang ZL; Jiang S Cancer Biomark; 2010-2011; 8(3):113-21. PubMed ID: 22012766 [TBL] [Abstract][Full Text] [Related]
7. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder. Yang Z; Yang Z; Xiong L; Huang S; Liu J; Yang L; Miao X Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):534-9. PubMed ID: 21415706 [TBL] [Abstract][Full Text] [Related]
8. [Expression of annexin A1 (ANXA1) and A2 (ANXA2) and its significance in benign and malignant lesions of gallbladder]. Yang LP; Yang ZL; Tan XG; Miao XY Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):595-9. PubMed ID: 21122411 [TBL] [Abstract][Full Text] [Related]
9. Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma. Liu DC; Yang ZL; Jiang S Pathol Oncol Res; 2011 Dec; 17(4):859-66. PubMed ID: 21455631 [TBL] [Abstract][Full Text] [Related]
10. MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder. Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S Mol Med Rep; 2016 Nov; 14(5):4581-4592. PubMed ID: 27748889 [TBL] [Abstract][Full Text] [Related]
11. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma. Yuan LW; Liu DC; Yang ZL Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):189-95. PubMed ID: 23558074 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329 [TBL] [Abstract][Full Text] [Related]
13. Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder. Yang L; Lan S; Liu J; Yang Z Diagn Pathol; 2011 Oct; 6():100. PubMed ID: 22018336 [TBL] [Abstract][Full Text] [Related]
14. Ornithine decarboxylase and glutamate decarboxylase 65 as prognostic markers of gallbladder malignancy: a clinicopathological study in benign and malignant lesions of the gallbladder. Deng X; Pei D Mol Med Rep; 2013 Feb; 7(2):413-8. PubMed ID: 23152127 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances. Shu GS; Lv F; Yang ZL; Miao XY Int J Clin Oncol; 2013 Aug; 18(4):641-50. PubMed ID: 22714709 [TBL] [Abstract][Full Text] [Related]
16. Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder. Yang L; Guo T; Jiang S; Yang Z Hepatogastroenterology; 2012 Sep; 59(118):1769-75. PubMed ID: 22172411 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma. Wang W; Yang ZL; Liu JQ; Yang LP; Yang XJ; Fu X Tumori; 2014; 100(6):667-74. PubMed ID: 25688501 [TBL] [Abstract][Full Text] [Related]
18. Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder. Zou Q; Xiong L; Yang Z; Lv F; Yang L; Miao X World J Surg Oncol; 2012 May; 10():92. PubMed ID: 22613496 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of galectin-3 and Sambucus nigra agglutinin binding site is associated with invasion, metastasis and poor-progression of the gallbladder adenocarcinoma. Yang LP; Jiang S; Liu JQ; Miao XY; Yang ZL Hepatogastroenterology; 2012 Oct; 59(119):2089-94. PubMed ID: 22497866 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma. Jiang S; Pei L; Yang ZL; Liu G Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]